CN Patent
CN101842079A — 非水性药物组合物
Assigned to Kyowa Kirin Services Ltd · Expires 2010-09-22 · 16y expired
What this patent protects
本发明提供一种用于鼻内递送药物的组合物,其包含:(i)该药物;及(ii)非水性媒介物,包含(a)丙二醇及至少另一种选自N-甲基吡咯烷酮、碳酸异丙烯酯、二甲亚砜及至少一种丙二醇脂肪酸酯的溶剂;(b)约40体积%至100体积%的N-甲基吡咯烷酮;或(c)约40体积%至100体积%的二甲亚砜(dimethyl sulfoxide,DMSO)。
USPTO Abstract
本发明提供一种用于鼻内递送药物的组合物,其包含:(i)该药物;及(ii)非水性媒介物,包含(a)丙二醇及至少另一种选自N-甲基吡咯烷酮、碳酸异丙烯酯、二甲亚砜及至少一种丙二醇脂肪酸酯的溶剂;(b)约40体积%至100体积%的N-甲基吡咯烷酮;或(c)约40体积%至100体积%的二甲亚砜(dimethyl sulfoxide,DMSO)。
Drugs covered by this patent
- Glucagen (GLUCAGON) · Xeris
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.